rs377578399
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_144508.5(KNL1):c.6334G>A(p.Val2112Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000233 in 1,460,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144508.5 missense
Scores
Clinical Significance
Conservation
Publications
- microcephaly 4, primary, autosomal recessiveInheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- autosomal recessive primary microcephalyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_144508.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KNL1 | NM_144508.5 | MANE Select | c.6334G>A | p.Val2112Ile | missense | Exon 21 of 26 | NP_653091.3 | ||
| KNL1 | NM_170589.5 | c.6412G>A | p.Val2138Ile | missense | Exon 22 of 27 | NP_733468.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| KNL1 | ENST00000399668.7 | TSL:1 MANE Select | c.6334G>A | p.Val2112Ile | missense | Exon 21 of 26 | ENSP00000382576.3 | ||
| KNL1 | ENST00000346991.9 | TSL:1 | c.6412G>A | p.Val2138Ile | missense | Exon 22 of 27 | ENSP00000335463.6 | ||
| KNL1 | ENST00000526913.5 | TSL:1 | n.3466G>A | non_coding_transcript_exon | Exon 12 of 18 | ENSP00000432565.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000160 AC: 4AN: 249446 AF XY: 0.0000148 show subpopulations
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1460720Hom.: 0 Cov.: 29 AF XY: 0.0000289 AC XY: 21AN XY: 726738 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:2
The V2138I variant in the CASC5 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The V2138I variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The V2138I variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is not conserved and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret V2138I as a variant of uncertain significance.
Microcephaly 4, primary, autosomal recessive Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at